Identification of alpha-1L adrenoceptor in rabbit ear artery.

The alpha-1L adrenoceptor (AR) was identified in rabbit ear artery by both functional and ligand binding studies. In functional studies using arterial rings, the contractile response to NS-49 [(R)-(-)-3'-(2-amino-1-hydroxyethyl)-4'-fluorometh-anesulfonanilide hydrochloride] (alpha-1A and alpha-1L AR-selective agonist) was competitively antagonized with low affinities by prazosin, RS-17053 [N-[2-(2-cyclopropylmethoxyphenoxy) ethyl]-5-chloro-alpha,alpha-dimethyl-1H-indole-3-ethamine hydrochloride], and 5-methylurapidil but with high affinities by tamsulosin and KMD-3213 [(-)-1-(3-hydroxypropyl)-5-[(2R)-2-([2-[(2,2,2-trifluoroethoxy)phenoxy]ethyl]amino)propyl]-2,3-dihydro-1H-indole-7-carboxamide]. In contrast, the response to noradrenaline (nonselective alpha-1 AR agonist) was inhibited noncompetitively by these antagonists (except 5-methylurapidil) with Schild slopes different from unity. These results suggest that the response to NS-49 was mediated predominantly via alpha-1L ARs, whereas the response to noradrenaline was produced through two distinct alpha-1 AR subtypes (presumably alpha-1B and alpha-1L ARs). In binding studies with intact segments of rabbit ear artery, [3H]KMD-3213 bound with high affinity (pKD=9.7) to alpha-1 ARs, which were subdivided by prazosin, RS-17053, and 5-methylurapidil into two subtypes (alpha-1A and alpha-1L ARs). In contrast, [3H]prazosin binding sites in ear artery segments (pKD = 9.8) were identified as alpha-1A and alpha-1B ARs. In conventional binding studies using isolated rabbit ear artery microsomal membranes, [3H]KMD-3213 binding sites were identified as alpha-1A ARs with high affinities for prazosin, RS-17053, and 5-methylurapidil. Our study indicates that an alpha-1L AR having a unique pharmacological profile coexists with alpha-1A and alpha-1B ARs in rabbit ear artery and can be identified either functionally or by binding studies using intact tissues but not microsomal membrane preparations.

[1]  M. Kunitomo,et al.  Alpha‐1D adrenoceptors are involved in reserpine‐induced supersensitivity of rat tail artery , 2004, British journal of pharmacology.

[2]  Li Zhang,et al.  Alpha‐1 adrenoceptors: evaluation of receptor subtype‐binding kinetics in intact arterial tissues and comparison with membrane binding , 2004, British journal of pharmacology.

[3]  M. Michel,et al.  Classification of α1-adrenoceptor subtypes , 1995, Naunyn-Schmiedeberg's Archives of Pharmacology.

[4]  Y. Akagi,et al.  Distribution of alpha‐1 adrenoceptor subtypes in RNA and protein in rabbit eyes , 2002, British journal of pharmacology.

[5]  J. Pediani,et al.  Quantitative imaging in live human cells reveals intracellular alpha(1)-adrenoceptor ligand-binding sites. , 2000, The Journal of pharmacology and experimental therapeutics.

[6]  J. Hieble,et al.  Adrenoceptor subclassification: an approach to improved cardiovascular therapeutics. , 2000, Pharmaceutica acta Helvetiae.

[7]  T. Taniguchi,et al.  Pharmacological analysis of the novel, selective α1‐adrenoceptor antagonist, KMD‐3213, and its suitability as a tritiated radioligand , 1999, British journal of pharmacology.

[8]  Y. Watanabe,et al.  Binding and functional characterization of alpha1-adrenoceptor subtypes in the rat prostate. , 1999, European journal of pharmacology.

[9]  Y. Watanabe,et al.  Alpha1-adrenoceptor subtypes and two receptor systems in vascular tissues. , 1998, Life sciences.

[10]  J. Hieble,et al.  Pharmacological characterization of the uroselective alpha-1 antagonist Rec 15/2739 (SB 216469): role of the alpha-1L adrenoceptor in tissue selectivity, part II. , 1997, The Journal of pharmacology and experimental therapeutics.

[11]  J. Blagg,et al.  Pharmacological options in the treatment of benign prostatic hyperplasia. , 1997, Journal of medicinal chemistry.

[12]  A. Ford,et al.  Pharmacological characterization of an α1A‐adrenoceptor mediating contractile responses to noradrenaline in isolated caudal artery of rat , 1997, British journal of pharmacology.

[13]  Astra Charnwood Pharmacological classification of a 1 -adrenoceptors mediating contractions of rabbit isolated ear artery: comparison with rat isolated thoracic aorta , 1997 .

[14]  I. Muramatsu,et al.  Pharmacological profiles of a novel alpha 1-adrenoceptor agonist, PNO-49B, at alpha 1-adrenoceptor subtypes. , 1995, Naunyn-Schmiedeberg's Archives of Pharmacology.

[15]  A. Goetz,et al.  BMY 7378 is a selective antagonist of the D subtype of alpha 1-adrenoceptors. , 1995, European journal of pharmacology.

[16]  H. Akino,et al.  Pharmacological characterization of alpha 1-adrenoceptor subtypes in the human prostate: functional and binding studies. , 1994, British journal of urology.

[17]  I. Muramatsu,et al.  Identification of alpha 1-adrenoceptor subtypes in the rat vas deferens: binding and functional studies. , 1992, British Journal of Pharmacology.